Drug Shortage Report for APO-RIVASTIGMINE

Last updated on 2018-01-22 History
Report ID 36947
Drug Identification Number 02336731
Brand name APO-RIVASTIGMINE
Common or Proper name RIVASTIGMINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) RIVASTIGMINE
Strength(s) 4.5MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100 BTL
ATC code N06DA
ATC description ANTI-DEMENTIA DRUGS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-01-22
Estimated end date
Actual end date 2018-01-22
Shortage status Resolved
Updated date 2018-01-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2018-01-22 French Compare
v2 2018-01-22 English Compare
v1 2018-01-22 English Compare

Showing 1 to 3 of 3